Aurteen Inc.

$41,000.00 CAD

≈ 6 months of average Canadian pay
Department
National Research Council Canada
Program
Industrial Research Assistance Program – Contributions to Firms
Recipient country
Canada
Fiscal year
2021-2022
Agreement period
October 1, 2021 – September 30, 2022
Reference
nrc-cnrc:172-2021-2022-Q3-980878

Published purpose

According to Health Canada, in 2019, about 11% of Canadians aged 20 and over were living with diabetes, and the rate has been increasing. Diabetes causes damage to blood vessels and leads to diabetic retinopathy (DR), ultimately leading to the growth of new vessels, called neovascularization (NV). NV can lead to retinal damage or separation, especially when the new vessels rupture. Presence of untreated NV is associated with loss of vision. In this project, the Firm proposes to develop digital image processing and machine learning techniques to detect, characterize, and analyze vascular patterns related to neovascularization and outcomes are expected to assist ophthalmologists in performing timely diagnosis and follow-up of patients with advanced DR.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions